The Department of Pediatric Oncology and Hematology - Your Expert Team for Pediatric Oncology in Berlin
At the Department of Pediatric Oncology and Hematology in Berlin-Wedding, children and adolescents with malignant diseases of the hematopoietic system, with benign and malignant tumors, with non-malignant, congenital or acquired disorders of hematopoiesis and blood clotting (sickle cell anemia, thalassemia, hemophilia) are treated and provided with aftercare.
Pediatric Oncology and Hematology at Charité – Universitätsmedizin Berlin
Cancer treatment at the Dept. of Pediatric Oncology and Hematology is based on scientifically proven therapeutic procedures - and usually lasts between three to 12 months. Approximately 120 children and adolescents receive pediatric oncology treatment at our department each year. The clinic has been certified as an Oncology Specialist Center by OnkoZert since 2017.
Stem cell transplantation is another focus in the Dept. of Pediatric Oncology and Hematology: The team led by Prof. Dr. Angelika Eggert performs approximately 40-50 transplants.
The Dept. of Pediatric Oncology and Hematology at Charité - Universitätsmedizin Berlin specializes in the treatment of
- acute lymphoblastic leukemias (relapsed leukemias),
- acute myeloid leukemias,
- brain tumors,
- neuroblastomas,
- Fanconi anemias,
- sickle cell disease,
- coagulation disorders,
- neurometabolic diseases (e.g. adrenoleukodystrophy) and
- Immunodeficiency diseases
The clinic also focuses on the treatment of children and adolescents with chronic blood disorders, such as sickle cell disease and thalassemia, as well as children and adolescents suffering from coagulation disorders. The coagulation outpatient clinic is a certified center of expertise.
The research department of the Dept. of Pediatric Oncology and Hematology is also dedicated to translational and clinical research of leukemias, neuroblastomas and other embryonal tumor diseases in childhood in various scientific projects.
In the treatment of children and adolescents with malignant diseases, pediatric oncology is guided by the high therapy standards and protocols of the Society for Pediatric Oncology and Hematology (GPOH) and other international pediatric oncology societies. Therapeutic findings are evidence-based. The Dept. of Pediatric Oncology and Hematology distances itself from the opinion that homeopathy has a place in pediatric oncological primary therapy.
